Orgenesis Inc. (ORGS) Financials

ORGS Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2024 29.7 million 53.6 million
June 30, 2024 30.6 million 46.4 million
March 31, 2024 30.9 million 58.5 million
Dec. 31, 2023 14.6 million 35.5 million

ORGS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2024 -4.7 million 2.2 million
June 30, 2024 -5.9 million 624000
March 31, 2024 -4.6 million 312000
Dec. 31, 2023 -557000 76000

ORGS Net Income

No data available :(

ORGS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2024 204000 10.1 million 2.2 million
June 30, 2024 77000 9.4 million 1.8 million
March 31, 2024 565000 24.3 million 1.8 million
Dec. 31, 2023 837000 19.1 million 334000

ORGS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2024 ?
June 30, 2024 38.9 million
March 31, 2024 33.2 million
Dec. 31, 2023 31.7 million

ORGS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2024 58000 4.5 million 2.7 million 350000
June 30, 2024 1000 1.5 million 2.1 million 281000
March 31, 2024 204000 2.3 million 6.0 million 3.2 million
Dec. 31, 2023 55000 3.0 million 26.5 million 43000

ORGS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2024 347000 585000
June 30, 2024 246000 538000
March 31, 2024 141000 758000
Dec. 31, 2023 -13.6 million 162000

ORGS Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ORGS

Price: $0.32

52 week price:
0.02
5.89

Earnings Per Share: -24.46 USD

P/E Ratio: -0.02

Exchange: OQX

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 23800

Market Capitalization: 2.6 million

Links: